Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Pereira-Martins DA, da Silva WF, Cavaglieri RC, Nardinelli L, Leal AM, Velloso EDRP, Bendit I, Câmara NOS, Schuringa JJ, Machado-Neto JA, Rego EM. Lima K, et al. Among authors: bendit i. Eur J Pharmacol. 2024 Aug 15;977:176723. doi: 10.1016/j.ejphar.2024.176723. Epub 2024 Jun 6. Eur J Pharmacol. 2024. PMID: 38851560
Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E. White HE, et al. Among authors: bendit i. Clin Chem. 2013 Jun;59(6):938-48. doi: 10.1373/clinchem.2012.196477. Epub 2013 Mar 7. Clin Chem. 2013. PMID: 23471097 Free article.
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial.
Cortes JE, De Souza CA, Ayala M, Lopez JL, Bullorsky E, Shah S, Huang X, Babu KG, Abdulkadyrov K, de Oliveira JSR, Shen ZX, Sacha T, Bendit I, Liang Z, Owugah T, Szczudlo T, Khanna S, Fellague-Chebra R, le Coutre PD. Cortes JE, et al. Among authors: bendit i. Lancet Haematol. 2016 Dec;3(12):e581-e591. doi: 10.1016/S2352-3026(16)30167-3. Lancet Haematol. 2016. PMID: 27890073 Clinical Trial.
Mdm2 mRNA expression in salivary gland tumour cell lines.
Mantesso A, Loducca SV, Bendit I, Garicochea B, Nunes FD, de Araújo VC. Mantesso A, et al. Among authors: bendit i. J Oral Pathol Med. 2004 Feb;33(2):96-101. doi: 10.1111/j.1600-0714.2004.00189.x. J Oral Pathol Med. 2004. PMID: 14720195
Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management.
Boquimpani CM, Abdo ANR, Martins DP, Lima LBA, Torriani MS, Bendit I. Boquimpani CM, et al. Among authors: bendit i. Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):50-57. doi: 10.1016/j.htct.2020.02.002. Epub 2020 May 25. Hematol Transfus Cell Ther. 2021. PMID: 32475788 Free PMC article.
MEG3 and MEG8 aberrant methylation in an infant with neuroblastoma.
Novak EM, Gimenez TM, Neves NH, Vince CC, Krepischi ACV, Lapa RM, Cristofani LM, Bendit I, Filho VO. Novak EM, et al. Among authors: bendit i. Pediatr Blood Cancer. 2020 Sep;67(9):e28328. doi: 10.1002/pbc.28328. Epub 2020 Jul 15. Pediatr Blood Cancer. 2020. PMID: 32667684 No abstract available.
85 results